new_0222_0359|PRLD|0|ps_ratio|price_to_book_value|peg_ratio|price|short_interest|dividend_yield|earning_yield|market_cap|pe_ratio|consensus_recommendation|price_target_num_est|price_target|sales_est_1y|sales_est_0y|eps_est_1y|eps_est_0y|ebitda_est_0y|ebitda_est_1y|revenues|ebitda|net_income|price_next_month|price_second_month
new_0222_0359|PRLD|1|Prelude Therapeutics Inc PS Ratio|Prelude Therapeutics Inc Price to Book Value|Prelude Therapeutics Inc PEG Ratio|Prelude Therapeutics Inc Price (USD)|Prelude Therapeutics Inc Short Interest|Prelude Therapeutics Inc Dividend Yield|Prelude Therapeutics Inc Earnings Yield|Prelude Therapeutics Inc Market Cap (USD)|Prelude Therapeutics Inc PE Ratio|Prelude Therapeutics Inc Consensus Recommendation|Prelude Therapeutics Inc Price Target Num Estimates|Prelude Therapeutics Inc Price Target (USD)|Prelude Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Prelude Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Prelude Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Prelude Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Prelude Therapeutics Inc EBITDA Estimates for Current Fiscal Year (USD)|Prelude Therapeutics Inc EBITDA Estimates for Next Fiscal Year (USD)|Prelude Therapeutics Inc Revenue (Quarterly) (USD)|Prelude Therapeutics Inc EBITDA (Quarterly) (USD)|Prelude Therapeutics Inc Net Income (Quarterly) (USD)||
new_0222_0359|PRLD|2|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_price|figure_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_whole_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0359|PRLD|4|quarterly|daily|quarterly|daily|monthly|daily|daily|daily|quarterly|monthly|monthly|monthly|quarterly|quarterly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly||
new_0222_0359|PRLD|5||1.44571428571||1.44759206799|15.25|1.44759206799|1.44759206799|1.44759206799||16.1379310345|18.72|18.72|101.5|50.75|22.2857142857|18|23.4|31.2||91.375|91.375||
new_0222_0359|PRLD|6||350||353|32|353|353|353||29|25|25|2|4|21|26|20|15||8|8||
new_0222_0359|PRLD|7|daily|daily|daily|market_daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly||
new_0222_0359|PRLD|20190915||||||||||||||||||||-6.785|-6.734||
new_0222_0359|PRLD|20191215||||||||||||||||||||-9.967|-10.039||
new_0222_0359|PRLD|20200315||||||||||||||||||||-9.605|-9.511||
new_0222_0359|PRLD|20200615||||||||||||||||||||-11.301|-11.408||
new_0222_0359|PRLD|20200915||5.7676||26.2|5757||-4.1218|1112.3105||||||||||||-18.002|-16.76|27.79|30.13
new_0222_0359|PRLD|20201015||6.4127||33.5|185019||-18.2748|1464.0639||3|2|35.5|||-1.8767|-1.77|-48.0606|-81.8209||||33.01|35.23
new_0222_0359|PRLD|20201115||6.6596||34.79|430032||-17.5972|1520.4413||2.3333|3|37|||-1.9167|-2.945|-50.9259|-84.0293||||36.06|51.47
new_0222_0359|PRLD|20201215||9.7569||50.97|709825||-12.0111|2227.5623||3|3|48|||-2.0767|-3.4933|-58.8926|-91.4793||-19.313|-19.25|49.96|71.55
new_0222_0359|PRLD|20210115||13.8955||67.46|1428194||-9.2687|2948.3865||3|2|42||||-1.945|-92.45|||||59.81|64.95
new_0222_0359|PRLD|20210215||15.2522||69.48|1426767||-8.9993|3236.2672||||||||||||||74.49|62.33
new_0222_0359|PRLD|20210315||14.8593||67.69|1381302||-9.2372|3152.8919||2.75|4|56|||-2.1667|-1.9525|-92.3666|-118.1187||-21.807|-21.3|62.53|43.33
new_0222_0359|PRLD|20210415||5.4131||41.25|1772847||-15.5858|1930.1246||2.75|4|62.5|||-2.954|-1.894|-94.3944|-122.2774||||41.81|41.44
new_0222_0359|PRLD|20210515||5.3241||40.48|2024407||-15.8823|1898.3825||2.6|5|62|||-2.978|-2.0167|-97.2406|-125.6186||||39.85|34.76
new_0222_0359|PRLD|20210615||4.3446||32.99|2571196||-19.4882|1549.151||||||||||||-27.723|-26.865|31.8|28.63
new_0222_0359|PRLD|20210715||4.0235||28.6|3553129||-23.568|1345.3068||2.2|5|62||||||||||27.77|32.04
new_0222_0359|PRLD|20210815||4.4639||31.73|4199815||-21.2431|1492.538||2.2|5|62|||-3.224|-2.2933|-109.2814|-173.8448||||32|35.69
new_0222_0359|PRLD|20210915||5.2226||37.08|4401831||-18.1781|1746.227||||||||||||-30.57|-30.687|38.65|31.25
new_0222_0359|PRLD|20211015||4.8126||31.74|4708591||-6.7752|1497.8677||2.2|5|52.2|||-3.246|-2.346|-110.5926|-194.6047||||31.61|17.58
new_0222_0359|PRLD|20211115||2.7778||18.32|5084313||-11.7382|864.5538||1.75|4|45.5|||-3.37|-2.4033|-113.9744|-199.3576||||18.33|14.29
new_0222_0359|PRLD|20211215||2.0859||13.75|4838073||-15.6396|649.2118||1.75|4|41.75|||-3.365|-2.4025|-113.9744|-199.3576||||14.27|12.45
new_0222_0359|PRLD|20220115||2.0055||13.22|5076915||-16.2666|624.1876||1.75|4|38|||-2.75|-3.375|-200.0456|-160.1351||||11.43|9.93
new_0222_0359|PRLD|20220215||1.5519||10.23|||-21.021|483.0135||||||||||||||9.71|10.03